Ligand validation:3W1W

CHD: CHOLIC ACID

CHD is a Ligand Of Interest in 3W1W designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3W1W_CHD_A_1502	67%	39%	0.122	0.93	0.76	1.58	1	9	0	0	100%	1
3W1W_CHD_B_504	66%	37%	0.12	0.925	0.75	1.69	-	7	1	0	100%	1
3W1W_CHD_A_1503	42%	46%	0.152	0.87	0.74	1.32	-	6	1	0	100%	1
3W1W_CHD_B_502	40%	48%	0.151	0.862	0.76	1.22	-	4	0	0	100%	1
3W1W_CHD_B_506	22%	56%	0.21	0.824	0.68	1.01	-	2	0	0	100%	1
3W1W_CHD_A_1504	22%	51%	0.254	0.868	0.78	1.1	1	2	0	0	100%	1
3W1W_CHD_B_503	16%	47%	0.279	0.853	0.8	1.24	-	6	0	0	100%	1
3W1W_CHD_A_1507	13%	48%	0.264	0.802	0.73	1.26	-	4	0	0	100%	1
3AQI_CHD_A_1	76%	4%	0.094	0.929	2.87	2.89	7	16	0	1	100%	1
2HRC_CHD_B_1605	52%	12%	0.136	0.892	2.15	1.88	16	17	0	0	100%	1
3HCP_CHD_A_3	45%	47%	0.151	0.881	0.75	1.29	-	6	0	0	100%	1
4F4D_CHD_B_503	37%	26%	0.151	0.848	0.94	2.01	-	11	0	0	100%	1
4KLA_CHD_A_502	31%	40%	0.21	0.88	0.75	1.56	-	9	2	0	100%	1
7TIE_CHD_G_107	98%	64%	0.052	0.977	0.64	0.75	-	-	0	0	100%	1
3AG2_CHD_B_304	97%	32%	0.063	0.981	1.03	1.63	3	12	0	0	100%	1
6NMP_CHD_C_303	96%	58%	0.075	0.982	0.56	1.02	-	2	1	0	100%	1
7VUW_CHD_B_305	96%	32%	0.064	0.97	1.01	1.67	-	13	0	0	100%	1
7YPY_CHD_B_303	95%	35%	0.057	0.962	1.09	1.48	2	10	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.